Patient Recruitment/Retention White Papers & Case Studies
-
2025 Trends In Patient Recruitment: From Disruption To Precision
3/27/2025
Explore the four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.
-
Safeguarding Personal Data: Protecting PII
3/17/2025
Learn about a secure, patient-centric platform that enables individuals to participate in clinical trials and registries while maintaining lifelong access to their data.
-
Navigating The Evolving Landscape Of Immunotherapy in Oncology
3/17/2025
Immunotherapy is revolutionizing oncology, enhancing patient outcomes through targeted treatments. This evolving landscape includes checkpoint inhibitors, and personalized medicine, shaping the future of cancer care.
-
BioPharma Services: Mobile Phlebotomy
2/21/2025
Explore how mobile phlebotomy is transforming clinical trial participation by making specimen collection more accessible, convenient, and patient-centric.
-
Elevating Patient Centricity In Clinical Trials
2/17/2025
How can the integration of patient perspectives throughout the clinical trial process enhance engagement and outcomes?
-
Access Six-Lead EKGs In Seconds With Medidata And AliveCor®
2/13/2025
Medidata's collaboration with AliveCor aims to revolutionize decentralized clinical trials, enabling objective cardiac safety assessments across diverse therapeutic areas.
-
Streamlining Phase 1 Trials With The Mobile Vision Pod
1/29/2025
A contract research organization formed a partnership to address significant challenges during a Phase 1 clinical trial for a corneal disease treatment through the use of a Mobile Vision Pod.
-
Expanding Diabetes-Related Eye Health Equity
1/29/2025
20/20 Onsite, American Diabetes Association and Genentech collaborated on an event to provide immediate diagnostic services, including retinal imaging and visual acuity assessments, directly on-site.
-
Overcoming Unexpected Obstacles In A Phase 1 Study
1/29/2025
Discover how the implementation of mobile vision clinics (MVCs) was used to enhance efficiency in a Phase 1 clinical trial.
-
Advancing Rare Disease Clinical Trials With Point-Of-Need Eye Assessments
1/29/2025
During the COVID-19 pandemic, Applied Genetic Technologies Corporation (AGTC) faced significant hurdles in enrolling participants due to travel restrictions and site limitations.